Ambarella, Inc. Announces Third Quarter Fiscal 2015

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ambarella, Inc. Announces Third Quarter Fiscal 2015 Financial Results

SANTA CLARA, Calif., Dec. 4, 2014 (GLOBE NEWSWIRE) -- Ambarella, Inc. (Nasdaq: AMBA ), a leading developer of low-power, HD video compression and image processing semiconductors, today announced financial results for its fiscal third quarter ended October 31, 2014.

Revenue for the third quarter of fiscal 2015 was $65.7 million, up 42.8% from $46.0 million in the same period in fiscal 2014. For the nine months ended October 31, 2014, revenue was $153.6 million, up 30.5% from $117.6 million for the nine months ended October 31, 2013.

Gross margin under U.S. generally accepted accounting principles (GAAP) for the third quarter of fiscal 2015 was 63.3%, compared with 63.7% for the same period in fiscal 2014. For the nine months ended October 31, 2014, GAAP gross margin was 63.6%, compared with 63.1% for the nine months ended October 31, 2013.

GAAP net income for the third quarter of fiscal 2015 was $18.3 million, or $0.57 per diluted ordinary share, compared with GAAP net income of $9.1 million, or $0.30 per diluted ordinary share, for the same period in fiscal 2014. GAAP net income for the nine months ended October 31, 2014 was $32.9 million, or $1.03 per diluted ordinary share. This compares with GAAP net income of $20.1 million, or $0.68 per diluted ordinary share, for the nine months ended October 31, 2013.

Gross margin on a non-GAAP basis for the third quarter of fiscal 2015 was 63.4%, compared with 63.8% for the same period in fiscal 2014. For the nine months ended October 31, 2014, non-GAAP gross margin was 63.7%, compared with 63.2% for the nine months ended October 31, 2013.

Non-GAAP net income for the third quarter of fiscal 2015 was $22.1 million, or $0.68 per diluted ordinary share. This compares with non-GAAP net income of $11.1 million, or $0.37 per diluted ordinary share, for the same period in fiscal 2014. Non-GAAP net income for the nine months ended October 31, 2014 was $41.8 million, or $1.31 per diluted ordinary share. This compares with non-GAAP net income of $25.0 million for the nine months ended October 31, 2013, or $0.84 per diluted ordinary share.

Ambarella reports gross margin, net income and earnings per share in accordance with GAAP and, additionally, on a non-GAAP basis. Non-GAAP financial information excludes the impact of stock-based compensation and the associated tax impact. A reconciliation of the GAAP to non-GAAP gross margin, net income and earnings per share numbers, as well as a description of the items excluded from the non-GAAP calculations, is included in the financial statements portion of this press release.

Total cash, cash equivalents and marketable securities on hand at the end of the third fiscal quarter of 2015 were $186.5 million, compared with $128.1 million at the end of the same quarter a year ago.

"We are delighted with our third quarter financial results," said Fermi Wang, president and CEO. "Our products for wearable sports and IP security cameras once again delivered strong revenue growth in the quarter, while the automotive aftermarket market also increased, reflecting strength in China and Korea. We also are very pleased with our progress in newer markets, such as wearable, home security and quadcopters cameras," he said.

Quarterly Conference Call

Ambarella plans to hold a conference call at 5 p.m. Eastern Time / 2 p.m. Pacific Time today with Fermi Wang, Chief Executive Officer, and George Laplante, Chief Financial Officer, to discuss third quarter 2015 results. The call can be accessed by dialing 877-304-8963 in the USA; international callers should dial 760-666-4834. The conference ID is 34844393. Participant passcode is "Ambarella ." Please dial in ten minutes prior to the scheduled conference call time. A live and archived webcast of the call will be available on Ambarella's website at http://www.ambarella.com/ for up to 30 days after the call.

About Ambarella

Ambarella, Inc. (Nasdaq: AMBA ), is a leading developer of low-power, high-definition (HD) video compression and image processing solutions. The company's products are used in a variety of HD cameras including IP security cameras, wearable sports cameras and automotive video camera recorders. Ambarella technology is also used in television broadcasting with TV programs being transmitted worldwide using Ambarella compression chips. For more information about Ambarella, please visit www.ambarella.com .

"Safe harbor" statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are not historical facts and often can be identified by terms such as "outlook," "projected," "intends," "will," "estimates," "anticipates," "expects," "believes," "could," or similar expressions, including the comments of our CEO relating to the expansion of our primary and new target markets and our ability to generate revenue from our solutions in these markets. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties and assumptions. Our actual results could differ materially from those predicted or implied and reported results should not be considered as an indication of our future performance.

The risks and uncertainties referred to above include, but are not limited to, risks associated with revenue being generated from new customers or design wins, neither of which is assured; our growth strategy; our ability to anticipate future market demands and future needs of our customers; our ability to introduce new and enhanced solutions; our ability to retain and expand customer relationships and to achieve design wins; our ability to successfully enter new markets; anticipated trends and challenges, including competition, in the markets in which we operate; our ability to effectively manage growth; our ability to retain key employees; and the potential for intellectual property disputes or other litigation.

Further information on these and other factors that could affect our financial results is included in the company's Annual Report on Form 10-K for our 2014 fiscal year, which is on file with the Securities and Exchange Commission. Additional information will also be set forth in the company's quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings the company makes with the Securities and Exchange Commission from time to time, copies of which may be obtained by visiting the Investor Relations portion of our web site at www.ambarella.com or the SEC's web site at www.sec.gov . Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. The results we report in our Quarterly Report on Form 10-Q for the third quarter ended October 31, 2014 could differ from the preliminary results announced in this press release.

Ambarella assumes no obligation and does not intend to update the forward-looking statements made in this press release, except as required by law.

Non-GAAP Financial Measures

The company has provided in this release non-GAAP financial information including non-GAAP gross margin, net income, and earnings per share, as a supplement to the condensed consolidated financial statements, which are prepared in accordance with generally accepted accounting principles ("GAAP"). Management uses these non-GAAP financial measures internally in analyzing the company's financial results to assess operational performance and liquidity. The company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning, forecasting and analyzing future periods. Further, the company believes these non-GAAP financial measures are useful to investors because they allow for greater transparency with respect to key financial metrics that the company uses in making operating decisions and because the company believes that investors and analysts use them to help assess the health of its business and for comparison to other companies. Non-GAAP results are presented for supplemental informational purposes only for understanding the company's operating results. The non-GAAP information should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from non-GAAP measures used by other companies.

The company has provided below reconciliations between its non-GAAP financial measures to its most directly comparable GAAP financial measures.

AMBARELLA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
(unaudited)
           
    Three Months Ended October 31, Nine Months Ended October 31,
    2014 2013 2014 2013
         
Revenue    $ 65,689  $ 45,990  $ 153,578  $ 117,641
           
Cost of revenue    24,130  16,689  55,887  43,356
Gross profit    41,559  29,301  97,691  74,285
           
Operating expenses:          
Research and development    15,584  13,476  41,995  35,767
Selling, general and administrative    7,324  5,761  20,954  16,303
           
Total operating expenses     22,908  19,237  62,949  52,070
           
Income from operations    18,651  10,064  34,742  22,215
           
Other income (loss), net    40  (12)  128  (28)
           
Income before income taxes    18,691  10,052  34,870  22,187
           
Provision for income taxes    364  926  1,973  2,066
           
Net income    $ 18,327  $ 9,126  $ 32,897  $ 20,121
           
Net income per share attributable to ordinary shareholders:          
Basic     $ 0.61  $ 0.33  $ 1.12  $ 0.73
Diluted     $ 0.57  $ 0.30  $ 1.03  $ 0.68
Weighted-average shares used to compute net income per share attributable to ordinary shareholders:          
Basic     30,006,896  27,836,086  29,467,178  27,432,301
Diluted     32,382,526  30,355,230  32,014,373  29,754,837

The following table presents details of stock-based compensation expense included in each functional line item in the condensed consolidated statements of operations above:

  Three Months Ended October 31,  Nine Months Ended October 31, 
  2014 2013 2014 2013
  (unaudited, in thousands)
Stock-based compensation:        
Cost of revenue  $ 97  $ 47  $ 214  $ 115
Research and development  2,363  1,385  5,582  3,259
Selling, general and administrative  1,824  1,029  4,311  2,286
Total stock-based compensation  $ 4,284  $ 2,461  $ 10,107  $ 5,660
         
AMBARELLA, INC.
RECONCILIATION OF GAAP TO NON-GAAP DILUTED EARNINGS PER SHARE
(in thousands, except share and per share data)
         
  Three Months Ended October 31, Nine Months Ended October 31,
  2014 2013 2014 2013
  (unaudited)
GAAP net income  $ 18,327  $ 9,126  $ 32,897  $ 20,121
Two-class method - allocation to participating securities  (1)  (8)  (8)  (27)
Treasury stock method - additional allocation to ordinary shares — — 1  2
GAAP net income - diluted  $ 18,326  $ 9,118  $ 32,890  $ 20,096
         
Non-GAAP adjustments:        
Stock-based compensation expense, net of tax effect  3,740  2,000  8,947  4,911
Two-class method - additional allocation to participating securities  (1)  (3)  (2)  (7)
Treasury stock method - additional allocation to ordinary shares — 1 — 1
Non-GAAP net income - diluted  $ 22,065  $ 11,116  $ 41,835  $ 25,001
         
GAAP - diluted weighted average shares  32,382,526  30,355,230  32,014,373  29,754,837
Non-GAAP - diluted weighted average shares  32,382,526  30,355,230  32,014,373  29,754,837
         
GAAP - diluted net income per share  $ 0.57  $ 0.30  $ 1.03  $ 0.68
Non-GAAP adjustments:        
Stock-based compensation expense, net of tax effect  0.11  0.07  0.28  0.16
Non-GAAP adjustment to two-class method diluted net income — — — —
Non-GAAP adjustment to treasury stock method diluted net income — — — —
Non-GAAP - diluted net income per share  $ 0.68  $ 0.37  $ 1.31  $ 0.84

The difference between GAAP and non-GAAP gross margin was 0.1% for each period, or $96,839 and $47,309 for the three months ended October 31, 2014 and 2013, respectively, or $213,697 and $114,946 for the nine months ended October 31, 2014 and 2013, respectively. The difference was due to the effect of stock-based compensation, and the associated tax impact, recorded for GAAP purposes.

AMBARELLA, INC. 
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands)
     
  October 31, January 31,
  2014 2014
     
ASSETS    
Current assets:    
Cash and cash equivalents  $ 146,577  $ 143,394
Marketable securities  39,951 —
Accounts receivable, net  40,965  18,837
Inventories  14,839  10,452
Restricted cash  3  3
Deferred tax assets, current  1,856  1,599
Prepaid expenses and other current assets  2,256  2,951
Total current assets  246,447  177,236
     
Property and equipment, net  3,182  3,018
Deferred tax assets, non-current  1,666  1,134
Other assets  1,983  1,919
Total assets  $ 253,278  $ 183,307
     
LIABILITIES AND SHAREHOLDERS' EQUITY    
Current liabilities:    
Accounts payable  20,830  8,321
Accrued liabilities  14,846  11,705
Income taxes payable  1,895  545
Deferred revenue, current  5,034  4,831
Total current liabilities  42,605  25,402
     
Deferred revenue, non-current  144 —
Other long-term liabilities  1,175  1,544
Total liabilities  43,924  26,946
     
Shareholders' equity:    
Preference shares — —
Ordinary shares  14  13
Additional paid-in capital  130,394  110,285
Accumulated other comprehensive income  (14) —
Retained earnings  78,960  46,063
Total shareholders' equity  209,354  156,361
Total liabilities and shareholders' equity  $ 253,278  $ 183,307

Deborah Stapleton 650.470.4200

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Avoid FOGs: Illinois Water's Holiday PSA

Updated Category News Views 86

Don't Ignore the Kitchen Sink This Holiday You ever poured something down the drain and just prayed it wouldn't come back to bite you later? Well, Illinois American Water is throwing up a big, red flag about doing exactly that during the holidays. When we're all busy passing the gravy boat and diving into festive feasts, it's easy to forget the after-party might just turn...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 17

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 0

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Caregiving's Financial Impact on Women: Insights from Cinergy

Updated Category News Views 84

Women Caregivers Face Financial Crossroads When it comes down to it, caregiving is one heck of a responsibility, particularly for women. It's about the sacrifices they make, not just in time but in financial security, too. Step away from a job to care for someone, and it's a dicey game you're playing with future income. The Cost of Generosity: Financial Impacts Cindy...

Continue Reading
iHeartMedia Faces 65% Drop: Fraud Investigation Launched

Updated Category News Views 0

Trouble Tunes for iHeartMedia Investors Alright folks, here's the skinny on iHeartMedia, Inc. These days, it's like everyone's out for a piece of iHeart, and not in the way you'd wanna see—unless you're SBS Law, those shareholder rights hotshots diving into another pond of legal ripples. Seems a heap of head-scratching's going down on their version of transparency with...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 28

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
DemandTec Leads the Pack in Retail Pricing Arena

Updated Category News Views 70

DemandTec's Climb to Retail Pricing Stardom The news hitting the streets is that DemandTec's carved out a top spot in QKS Group's SPARK Matrix™ for Intelligent Retail Pricing & Promotion Optimization for 2026. In an industry filled with slick operators and gimmicks, it takes some real chops to stand out. They've clinched this position by rolling out a platform that ties...

Continue Reading
Alliance for Women in Media Champions Change in 2026

Updated Category News Views 39

A Celebration of Trailblazing Women in Media If there's one thing I've learned about strong leadership, it's that you can't fake authenticity. Today, we're tipping our hats to some genuine trailblazers. The Alliance for Women in Media (AWM) held its annual Gracies Leadership Awards, celebrating the achievements and vision of seven remarkable women. Honoring the...

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 51

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading

Top 5 Most Recently Viewed Articles

GrandCare Health Services Enhances Revenue with Smart Solutions

Updated Category News Views 120

GrandCare Health Services Takes a New Approach to Revenue Management In a strategic move to enhance its financial efficiency, GrandCare Health Services has recently partnered with Homecare Homebase (HCHB), a leading provider of cloud-based technological solutions designed for home health agencies. This collaboration specifically focuses on optimizing revenue cycle...

Continue Reading
Westland Insurance Expands its Ontario Footprint with Acquisition

Updated Category News Views 216

Westland Insurance Expands its Ontario Presence Westland Insurance, a prominent name in Canada’s insurance market, has made strides in enhancing its reach with the acquisition of Paul Ayotte Insurance Brokers Ltd. This strategic move aims to solidify Westland’s footprint in Ontario, allowing for improved service delivery to local clients. This acquisition not only...

Continue Reading
First Industrial Realty Trust Set for Q3 Results Conference Call

Updated Category News Views 50

First Industrial Realty Trust, Inc. (NYSE: FR) faced a pivotal moment back in late 2024, gearing up to unveil its third-quarter numbers. The desks were buzzing as traders anticipated this call—a regular event but always loaded with potential surprises. Q3 Results Anticipation: Supply Chain Stakes or Investor Optimism? On that Thursday morning, scheduled for 10:00 a.m....

Continue Reading
Fannie Mae Panel Predicts Slowdown in Future Home Prices

Updated Category News Views 217

Fannie Mae's Expert Insights on Home Price Trends A recent survey conducted by Fannie Mae proves insightful for those watching the housing market, as it sheds light on anticipated changes in home prices in the coming years. The report indicates that after an increase of 5.3% in 2024, experts expect a more moderate growth of approximately 2.4% for 2025 and 2.1% for 2026....

Continue Reading
PenKid Biomarker Revolutionizes Kidney Therapy Decisions

Updated Category News Views 31

The Emergence of PenKid in Critical Care You ever get the feeling that the old ways just aren’t cutting it anymore? That’s where this penKid news rolls in like a breath of fresh air. In the world of ICU management, especially with kidney replacement therapy (KRT), this little biomarker is flipping the script on traditional biomarkers. Imagine 1,436 critically ill...

Continue Reading